Futura Medical (LON:FUM) Trading Down 11.5% – What’s Next?

Shares of Futura Medical plc (LON:FUM) traded down 11.5% during mid-day trading on Wednesday . The company traded as low as GBX 0.45 and last traded at GBX 0.46. Approximately 2,226,471 shares traded hands during trading, a decline of 74% from the average daily volume of 8,569,635 shares. The stock had previously closed at GBX 0.52.

Futura Medical Trading Down 11.5%

The stock has a market capitalization of £2.67 million, a PE ratio of -0.17 and a beta of 0.02. The firm’s 50-day simple moving average is GBX 0.76 and its two-hundred day simple moving average is GBX 1.06.

Futura Medical (LON:FUM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The business had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. As a group, research analysts expect that Futura Medical plc will post 2.8486672 earnings per share for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.